Pure Global

Impact of Probiotics on Children With ADHD - Trial NCT06348121

Access comprehensive clinical trial information for NCT06348121 through Pure Global AI's free database. This phase not specified trial is sponsored by Wecare Probiotics Co., Ltd. and is currently Not yet recruiting. The study focuses on Attention Deficit Hyperactivity Disorder. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06348121
Not yet recruiting
dietary supplement
Trial Details
ClinicalTrials.gov • NCT06348121
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Impact of Probiotics on Children With ADHD
Effect of WecProB on Clinical Features and Gut Microbiota of Attention Deficit Hyperactivity Disorder in Children

Study Focus

Probiotic

Interventional

dietary supplement

Sponsor & Location

Wecare Probiotics Co., Ltd.

Timeline & Enrollment

N/A

May 07, 2024

Dec 31, 2024

80 participants

Primary Outcome

Clinical symptoms of ADHD

Summary

To evaluate the efficacy and safety of probiotic product WecProB as food supplements for the
 treatment of clinical symptoms in children with ADHD, in comparison with placebo.

ICD-10 Classifications

Neurotic disorder, unspecified
Hyperkinetic disorder, unspecified
Habit and impulse disorder, unspecified
Mild cognitive disorder
Disturbance of activity and attention

Data Source

ClinicalTrials.gov

NCT06348121

Non-Device Trial